Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Neurofilament Light With the Development and Severity of Parkinson Disease
Shannon Halloway, Pankaja Desai, Todd Beck, et al.
Neurology (2022) Vol. 98, Iss. 22
Open Access | Times Cited: 22

Showing 22 citing articles:

Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers
Yi‐Han Gan, Lingzhi Ma, Yi Zhang, et al.
Nature Aging (2025)
Closed Access | Times Cited: 1
Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease
Yuhong Fu, Liche Zhou, Hongyun Li, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 861-879
Open Access | Times Cited: 34
The 2022 Lady Estelle Wolfson lectureship on neurofilaments
Axel Petzold
Journal of Neurochemistry (2022) Vol. 163, Iss. 3, pp. 179-219
Open Access | Times Cited: 30
Association between depressive symptoms and cognitive function in the older population, and the mediating role of neurofilament light chain: Evidence from NHANES 2013–2014
Ying Xu, An Chen, Rucheng Chen, et al.
Journal of Affective Disorders (2024) Vol. 360, pp. 221-228
Open Access | Times Cited: 6
Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease
Ni Liu, Tianjiao Zhang, Wei Zhao, et al.
Ageing Research Reviews (2025), pp. 102658-102658
Closed Access
Cardiovascular Health and Biomarkers of Neurodegenerative Disease in Older Adults
Anisa Dhana, Charles DeCarli, Klodian Dhana, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250527-e250527
Open Access
Biomarkers in Parkinson’s disease: A state of the art review
Kyla Y. Yamashita, Sweta Bhoopatiraju, Bret Silverglate, et al.
Biomarkers in Neuropsychiatry (2023) Vol. 9, pp. 100074-100074
Open Access | Times Cited: 12
From Cell Architecture to Mitochondrial Signaling: Role of Intermediate Filaments in Health, Aging, and Disease
Emanuele Marzetti, Rosa Di Lorenzo, Riccardo Calvani, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1100-1100
Open Access
Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease
Dehao Yang, Haobo Xie, Sheng Wu, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Emerging Trends: Neurofilament Biomarkers in Precision Neurology
Priti Sharma, Aditi Giri, Prabhash Nath Tripathi
Neurochemical Research (2024)
Closed Access | Times Cited: 3
Toward preventing Parkinson’s disease
Brit Mollenhauer, Christine A. F. Von Arnim
Science (2022) Vol. 377, Iss. 6608, pp. 818-819
Closed Access | Times Cited: 15
NfL as Analogue of C-Reactive Protein in Neurologic Diseases
Lorenzo Gaetani, Lucilla Parnetti
Neurology (2022) Vol. 98, Iss. 22, pp. 911-912
Closed Access | Times Cited: 10
Association between cadmium exposure and serum neurofilament light chain levels: A nationwide population-based survey
Jing Luo, Song Lin
Ecotoxicology and Environmental Safety (2024) Vol. 282, pp. 116771-116771
Open Access | Times Cited: 1
Screening and Targeting Risk Factors for Prodromal Synucleinopathy: Taking Steps toward a Prescriptive Multi-modal Framework
Lee E. Neilson, Joseph F. Quinn, Miranda M. Lim
Aging and Disease (2023)
Open Access | Times Cited: 3
Serum Neurofilament Light-Chain Concentrations in Essential Tremor: a Case–Control Study
Meagen Salinas, Victor H. Salinas, Maisie McGurn, et al.
The Cerebellum (2023) Vol. 23, Iss. 3, pp. 951-956
Closed Access | Times Cited: 3
Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study
Shannon Halloway, Denis A. Evans, Pankaja Desai, et al.
Journal of the American Geriatrics Society (2023) Vol. 72, Iss. 1, pp. 149-159
Open Access | Times Cited: 2
The association between cadmium exposure and axonal injury biomarker, serum neurofilament light chain levels in US adults
Jing Luo, Song Lin
Research Square (Research Square) (2024)
Open Access
High levels of plasma neurofilament light chain correlated with brainstem and peripheral nerve damage
Takumi Nakamura, Takeshi Kawarabayashi, Makoto Shibata, et al.
Journal of the Neurological Sciences (2024) Vol. 463, pp. 123137-123137
Closed Access
Association of subjective memory complaints with serum biomarkers of neurodegeneration and cognition: A population‐based study
Anisa Dhana, Charles DeCarli, Klodian Dhana, et al.
Journal of the American Geriatrics Society (2024)
Closed Access
Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease
Mika Shimamura, Kong Weijie, Toshiaki Nonaka, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 8-8
Open Access
Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson’s disease
Xu Liu, Xuanjing Liu, Yuning Liu, et al.
Brain Research (2023) Vol. 1822, pp. 148660-148660
Closed Access
Reader Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use
Tjalf Ziemssen
Neurology (2022) Vol. 99, Iss. 19, pp. 868-868
Closed Access
Page 1

Scroll to top